Холестерин, ЛПНП и когда нужны статины | Владимир Алипов

Dr. Alipov begins by explaining that while research shows LDL reduction can reduce cardiovascular problems, this depends entirely on the individual's health state. He warns that reducing LDL below normal values, especially in young people, is pointless and can be harmful. He then provides a detailed explanation of atherosclerosis, describing how atherosclerotic plaques form in vessel walls as accumulations of cholesterol and lipids. These plaques can either block vessels directly or rupture and cause thrombosis, leading to myocardial infarction when coronary arteries are affected. The doctor explains cholesterol metabolism, noting that cholesterol comes from diet or liver synthesis (where statins act to disrupt synthesis). He emphasizes cholesterol's essential functions: synthesis of steroid hormones (testosterone, estrogen, cortisol), vitamin D production, bile acid formation, and serving as a structural membrane component. He describes how LDL lipoproteins transport cholesterol from liver to tissues, while HDL can return excess cholesterol to the liver. Problems arise when people have elevated LDL levels, slow LDL clearance, or modified LDL properties that cause abnormal cholesterol deposition in vessel walls. Various factors like smoking, hypertension, diabetes, or vessel damage can promote atherosclerotic plaque formation. For high-risk individuals with these conditions, LDL reduction through statins is justified as it reduces mortality and cardiovascular events. However, he strongly criticizes the biohacker mentality of universal statin use, emphasizing that what works for some can be meaningless or dangerous for others.